Siemens Healthineers AG Registered Shares SHL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SHL is a good fit for your portfolio.
News
-
Siemens Healthineers Profit Rises on Revenue Growth
-
GE HealthCare's stock slides after UBS downgrades to sell
-
Siemens Healthineers Net Profit Falls on Higher Costs, Taxes
-
Siemens Healthineers Weighs Sale, Carve-Out of Diagnostics Unit, Bloomberg Reports
-
Siemens Healthineers Gets 20-Year Belfast Hospital Contract
-
Siemens Healthineers Shares Slide After Varian Disappoints
-
Siemens Healthineers Net Profit Rose on Lower Taxes
-
Siemens Healthineers Shares Fall After Decline in 2Q Earnings, Revenue
Trading Information
- Previous Close Price
- €52.50
- Day Range
- €52.62–52.88
- 52-Week Range
- €44.70–57.78
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €58.71 Bil
- Volume/Avg
- 0 / 8
Key Statistics
- Price/Earnings (Normalized)
- 30.67
- Price/Sales
- 2.71
- Dividend Yield (Trailing)
- 1.81%
- Dividend Yield (Forward)
- 1.81%
- Total Yield
- 2.48%
Company Profile
Siemens Healthineers AG is engaged in the fields of diagnostic, therapeutic imaging, laboratory and point of care diagnostics as well as clinical consulting services. The imaging segment products equipment include magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging and ultrasound. The portfolio of the Diagnostics segment includes; immunochemistry, hematology, coagulation, urinalysis, etc. Advanced Therapies segment products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology and surgery. Varian segment provides multi-modality cancer care technologies, solutions and services to oncology departments in hospitals and clinics. It caters and earns revenue from Europe, the Middle East, Africa, China and others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Growth
- Total Number of Employees
- 71,400
Comparables
Valuation
|
Metric
|
SHL
|
AFX
|
RHK
|
|---|---|---|---|
Price/Earnings (Normalized) | 30.67 | 31.00 | 12.25 |
Price/Book Value | 3.29 | 4.04 | 0.65 |
Price/Sales | 2.71 | 4.09 | 0.55 |
Price/Cash Flow | 23.79 | 26.00 | 8.80 |
Price/Earnings
SHL
AFX
RHK
Financial Strength
|
Metric
|
SHL
|
AFX
|
RHK
|
|---|---|---|---|
Quick Ratio | 0.70 | 2.34 | 2.21 |
Current Ratio | 1.12 | 3.51 | 2.35 |
Interest Coverage | 6.25 | 19.18 | 11.05 |
Quick Ratio
SHL
AFX
RHK
Profitability
|
Metric
|
SHL
|
AFX
|
RHK
|
|---|---|---|---|
Return on Assets (Normalized) | 3.34% | — | 2.24% |
Return on Equity (Normalized) | 8.61% | — | 3.15% |
Return on Invested Capital (Normalized) | 9.39% | — | 2.38% |
Return on Assets
SHL
AFX
RHK
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ddrxyzhwq | Ffzwtf | $182.6 Bil | |
SYK
| Stryker Corp | Qzcxtlkwwm | Srwk | $125.9 Bil | |
MDT
| Medtronic PLC | Dzyrrtc | Tgqxcrp | $108.3 Bil | |
BSX
| Boston Scientific Corp | Fljybsq | Fqsyp | $106.9 Bil | |
EW
| Edwards Lifesciences Corp | Kcxkwgdhb | Xnltfh | $51.0 Bil | |
DXCM
| DexCom Inc | Wcwqrpyq | Kvyk | $50.3 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Fzrpkjbxvj | Gfkn | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Tlfxchzd | Hzwnwc | $24.3 Bil | |
ALGN
| Align Technology Inc | Lhmdwjb | Cctnt | $21.1 Bil | |
PODD
| Insulet Corp | Hqvydjzvyh | Clmcjf | $12.4 Bil |